Abstract
Osteonecrosis of the femoral head (ONFH) is a significant cause of both pain and disability that often affects young adults during what ought to be their most productive age. Two broad categories of ONFH exist: traumatic and non-traumatic. Traumatic ONFH results from acute mechanical disruption of the femoral head’s blood supply. Many factors that increase the risk of non-traumatic osteonecrosis have been identified. Steroid-induced osteonecrosis of the femoral head (SONFH) is the most common form of non-traumatic ONFH. Many hypotheses as to the pathogenesis of SONFH have been proposed, including intravascular thrombosis, abnormal fat metabolism, intramedullary adipocyte hypertrophy, and osteoporosis; however, the exact mechanism of SONFH is still not clearly understood. Animal models using rats, mice, rabbits, chickens, pigs, and emus have been used to study SONFH. Unfortunately, these models each have limitations. Therefore, it is necessary to establish a reproducible model that better simulates human disease. The present review is intended to summarize the currently available models, evaluative indicators, and application of current understanding to both the prevention and treatment of SONFH.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Glucocorticoids are inexpensive, effective, and widely used for conditions both acute and chronic, including severe acute respiratory syndrome (SARS), asthma, rheumatoid arthritis (RA), systemic lupus erythematous (SLE), and organ transplantation. Despite their utility, glucocorticoids have been recognized as a major risk factor of ONFH, with ONFH occurring in up to 13% of patients on high doses (> 3 g cumulative) of glucocorticoids [1,2,3,4,5]. Femoral head collapse—the end stage of ONFH—requires total hip arthroplasty, a procedure that carries with it both morbidity and significant economic burden to the patient and the health care system at large. Preventing the stepwise accumulation of insulting events that lead to ONFH would allow for effective steroid treatment while avoiding femoral head collapse. Though multiple studies have established a causal relationship between steroids and ONFH, an ideal animal model has not yet been created. It is therefore essential to establish an animal model of SONFH and femoral head collapse that mimics the human clinical aetiology [6, 7]. The present review is intended to summarize the currently available models, evaluative indicators, and application of current understanding to both the prevention and treatment of SONFH.
Animal models of SONFH
Rabbit
Rabbits are the most commonly used animal model for SONFH. They share mammalian characteristics with humans and are simple to acquire, cheap to maintain, and easy to breed. Many mechanisms for the pathogenesis of SONFH have been proposed, but no consensus yet exists as to the exact mechanism. Glucocorticoids directly inhibit differentiation of osteogenic progenitors to osteoblasts while simultaneously promoting adipocyte formation and deposition [8,9,10]. Liu et al. [8] found that impaired osteogenic differentiation associated with connexin43/microRNA-206 is implicated in SONFH. Fan et al. [9] found that hypoxia inducible factor prolyl hydroxylase inhibitor prevents SONFH in rabbits by promoting angiogenesis and inhibiting apoptosis. Li et al. [10] found that small interfering RNA (siRNA) that targets the PPARγ gene inhibits adipocytic differentiation of bone marrow mesenchymal stems cells (BMSCs) and prevents SONFH in rabbits.
The vascular milieu has been implicated in rabbit models of SONFH. Wu et al. [11] and Kang et al. [12] found that the increased levels of membrane microparticles and platelets seen in SONFH may be related to hypercoagulability, thrombosis, and inflammation in the microcirculatory environment. Meanwhile Guan et al. [13] showed that hypercoagulability potentiates thrombus formation in the presence of SONFH. In addition, vascular endothelial growth factor (VEGF), an important mediator of angiogenesis and overall vascular function [14], was found by Wang et al. [15] to be decreased in animals treated with glucocorticoids. Decrease VEGF and VEGF mRNA levels correlated with diminished femoral head blood flow, a precursor to ONFH.
In recent years, a number of different treatment options for ONFH have been proposed. Li et al. [16], He et al. [17], Yuan et al. [18], QI et al. [19], and Wu et al. [20] have reported that traditional Chinese medicine (such as Tao-Hong-Si-Wu Decoction and Gu fu sheng) can promote blood flow, the expression of endothelial cell growth factor and insulin-like growth factor, reduce the expression of tumour necrosis factor, and protect endothelial cells and prevent them from apoptosis. Given that apoptosis, endothelial growth, and blood flow disturbances have been implicated in ONFH, these traditional treatment regimens could potentially reduce the incidence of SONFH. Kang et al. [21] and Nishida et al. [22] found Hmg CoA reductase inhibitors (statins) inhibit the formation of fat and reduce blood lipid and free fatty acid concentrations, thereby reducing the risk of SONFH. In a follow-up study, Kang et al. [23] found that the synergistic effect of treatment with an anti-coagulant (enoxaparin) agent and a lipid-lowering (lovastatin) agent reduced the incidence of SONFH in rabbits. Similar results were found when Beckmann et al. [24] built a rabbit model of SONFH through a single intramuscular injection 20 mg/kg methylprednisolone, and found that a therapy group receiving subsequent enoxaparin had decreased rates of SONFH.
Vitamin E has recently become a substance of interest for the treatment and prevention of SONFH. It has been reported by Kuribayashi et al. [25], MIKAMI et al. [26], and JIA et al. [27] that vitamin E may prevent SONFH by inhibiting steroid-induced oxidative stress, alleviating DNA oxidative damage in bone marrow haematopoietic cells and therefore decreasing rates of apoptosis.
T. Asadal et al. [28] and Kang et al. [29] reported that direct injection of autologous bone marrow cells and strontium-doped calcium polyphosphate combined bone marrow mononuclear cells into femurs and prevents SONFH in rabbits. On the basis of these studies, Sun et al. [30, 31] and Xie et al. [32] found that the combination of bone marrow mononuclear cells or endothelial progenitor cells with surgical core decompression enhances neovascularization and bone regeneration in rabbit SONFH, which may provide a novel and effective therapeutic option for early SONFH. In addition, a variety of compounds including sodium ferulate [33], resveratrol [34], nitrate [35], recombinant human fibroblast growth factor microspheres[36], and hydroxysteroid dehydrogenase [37] have shown promise as preventative and therapeutic options for SONFH.
Rat
Rats have long been used as animal models of human disease. Easy to feed, and breed, they grow quickly and share both physiologic and metabolic characteristics with humans. Their moderate size makes their femoral head suitable for both imaging and pathology based studies [38]. Zhang et al. [39] injected methylprednisolone (MPS, 20 mg/kg) into rates weekly and found that MPS significantly damaged the blood supply to the femoral head. In contrast, they found that Vitamin K2 improved blood supply to the femoral head and prevented development SONFH in MPS treated rats.
Adipogenesis and fatty deposition are important causes of SONFH. Han et al. [40,41,42] reported successively in three articles that enhanced P-glycoprotein activity decreased the risk of SONFH by inhibiting adipogenesis in the femoral head. In these studies, rifampicin was shown to reduce SONFH risk by enhancing glycoprotein activity.
Nozaki et al. [43] studied the effect of lipid-lowering agents on SONFH. They induced adipocyte deposition by injecting 4 mg methylprednisolone acetate (MPLS) subcutaneously into the back of 38 stroke-prone spontaneously hypertensive rats (SHRSP), which led to adipocyte deposition in bone marrow and hyperlipidemia. Pravastatin treatment prevented SONFH in these rats by decreasing blood lipid levels, oxidative stress, and adipocyte formation. Jiang et al. [44] found that pravastatin treatment prevented SONFH in Wistar rats who had received MPLS injections by enhancing angiogenesis in rat femoral heads, decreasing circulating lipids levels, suppressing PPARγ expression, and activating Wnt signaling pathway. Subsequently, Zhang et al. [45] found that SONFH was caused by apoptosis which was linked to the Wnt/β-catenin pathway. Yu et al. [46, 47] found that lithium or lithium chloride can stabilize osteogenic-adipogenic homeostasis by activating the β-catenin pathway and thereby preventing development of SONFH.
Oxidative stress has repeatedly been shown to contribute to SONFH in rate models. Nozaki et al. [43] reported that corticosteroids increase oxidative stress. The toll-like receptor 4 (TLR4) pathway was implicated in SONFH by Okazaki et al. [48] and Tian et al. [49], who found that corticosteroids SONFH by disturbing the immune response via TLR4 signaling pathway. Subsequently, Erkam Komurcu et al. [50] and Miyata et al. [51] found that coenzyme Q10 prevented SONFH by reducing oxidative stress. Pentosan, a semi-synthetic polysulfated xylan appears to reduce the incidence of ONFH in SHRSP by improving lipid metabolism and decreasing oxidative stress. A single study has called in to question among oxidative stress, TLR4, and SONFH. S. Okazaki et al. [52] found that TLR4 stimulation by lipopolysaccharide administration increased the incidence of SONFH, but concomitant oxidative stress via TLR4 signaling did not contribute to the development of SONFH.
In recent years, many attempts to elucidate the genetic contributors to SONFH have been undertaken. Tong et al. [53] performed gene array analysis on a rat model of SONFH, confirmed the microarray results by using a quantitative RT-PCR and immunohistochemistry (IHC) assays. In their SONFH group, 190 individual genes showed differential expression relative to healthy controls, with 52 being upregulated and 138 being downregulated. The majority of the genes in question were associated with oxidative stress pathways, signal transduction, apoptosis, lipid metabolism, and extra-cellular matrix proteins. The microarray analysis of gene expression in rat model by Kerachian et al. [54] concluded that rat SONFH may be mediated byalpha-2 macroglobulin (A2M), though subsequently Carli et al. [55] found that elevated serum levels of A2M were not predictive of early SONFH in rodents. The elevated A2M levels observed during glucocorticoid treatment suggest that it may play a role in the host reparative response; therefore, A2M’s contribution to SONFH warrants further study.
Zhao et al. [56] have shown that microRNA-145 mediates SONFH through targeting the OPG / RANK / RANKL signaling pathway. In addition, Tao et al. [57], Chen et al. [58], Wu et al. [59], Shi et al. [60], CHEN et al. [61], and Dong et al. [62] have recently explored the prevention and treatment of SONFH through modulation of signaling pathways, Chinese medicine, gene expression, osteogenesis, inhibition of adipogenesis, and inhibition of apoptosis, respectively. The aforementioned rat-model studies have not completely elucidated the aetiology or optimal treatment of SONFH, but point in the way toward future fruitful research avenues.
Mouse
Mice are affordable and easy to breed. They reproduce rapidly and possess a skeletal system grossly similar in development to humans [63]. However, the mouse femoral head is relatively small, which prevents reliable characterization of mouse ONFH on MRI and CT. This limits the utility of mouse models. Ryoo et al. [64] induced SONFH in female BALB / cAnN / CrljBgi mice through prednisolone treatment. Repeated administration of LPS to these mice showed development of SONFH more strongly associated with TNFα levels in the femoral head, rather than cytokine levels in immune tissues. Wang et al. [65] induced SONFH in C57BL/6J mice using MPS (21 mg/kg). They found 23 bone marrow miRNA expression variations in the experimental group, including 7 upregulated and 16 downregulated. The results of reverse transcriptase-quantitative polymerase chain reaction (RT-PCR) supported the results of their microarray assay, indicating that SONFH may cause miRNA changes in BMSCs.
Yang et al. [66] evaluated the effect of continuous glucocorticoid therapy versus discontinuous therapy in 14 different strains of mice and found that discontinuous treatment led to lower rates of SONFH despite comparable cumulative doses between the two groups. This suggests that prevention may be achieved, in part, through judicious dosing regimens.
Chicken
Chickens are small, cheap, and easy to raise birds. Though they do not share a mammalian heritage with humans, the bipedal gait of chickens places stresses across their hips more similar to human than those seen by small mammalian quadrupeds like mice and rats. Cui et al. [67] studied a chicken model of SONFH by selecting injecting 48 chickens with MPS (3 mg/kg) on a once weekly basis. Empty bone lacuna and bone marrow necrosis were seen after only six weeks of this regimen. A cohort of chickens injected treated with both MPS and lovastatin were observed to have less bone resorption and no bony necrosis. Chen et al. [68] looked at the molecular messengers associated with SONFH in chickens. They fed MPS sodium succinate (5.2 mg/kg) to 32 healthy female Leghorn chickens once weekly for eight weeks. Hyperlipidemia, thin trabecula, increased number of empty lacuna and adipocyte proliferation, and hypertrophia were observed in MPS chickens. These changes were accompanied by increased expression of RANKL and Smad7. Decreased levels of OPG, BMP2, TGFβ1, and Smad4 were seen in the treated mice. Huogo I Formula, a traditional Chinese medicine, has been shown to decrease rates of SONFH. Erken et al. [69] used a similar model for SONFH, injecting MPS (3 mg/kg/week) intramuscularly into Leghorn chickens. They found that treatment with pentoxifylline decreased rates of SONFH.
While these studies have corroborated small mammal molecular mechanism and treatment regimens for SONFH, Xu et al. [70] performed an anatomic study of the blood supply to the chick femoral head. The study found that only the acetabular branch of the femoral artery, lateral retinacular artery, trochanteric artery, and the ascending branch of the middle femoral nutrient artery perfuse the chicken femoral head. The femoral circumflex artery, whose branches perfuse the majority of the human femoral head, merely perfuses the chicken thigh musculature. This difference in vascular anatomy do calls into question the degree to which the chicken model accurately mimics human disease.
Emu
Small mammals and chickens have most often been used to model SONFH. The convenience of working with small animals comes at a cost: hormone induction in these animals has not been found to cause true structural collapse of the femoral head, the final and most morbid stage of human SONFH. Emus, massive bipedal birds, do experience true femoral head collapse when osteonecrosis occurs [6]. The size, weight, and biomechanical similarities shared by humans and emus make this bird a useful model for studying SONFH [71,72,73]. Recognition of this fact has led an increasing number of research groups to study the emu model of ONFH. Conzemius et al. [71], Reed et al. [74], and Fan et al. [75] conducted studies on temperature-induced osteonecrosis of the emu femoral head. They found that cryogenic insults as well as vast temperature swing alternating between freezing and heating episodes led to eventual collapse of the femoral head. Zheng et al. [6] made the emu model directly applicable to SONFH with their study of LPS- and MPS-induced emu ONFH, finding that 70% of emus treated with the combination of toxin and steroid went on to femoral head collapse. Untreated emus did not develop ONFH or collapse.
While the similarities between end stage emu and human SONFH make the birds an attractive model organism, the birds are rare relative to the abundant traditional small lab mammal. Many animal research facilities have neither experience with, nor access to emus. As more studies establish the utility of the emu model, it would be prudent to pursue this model in the transition from small mammal to human clinic studies.
Other animal models
In recent years, animal models of ONFH have also been reported in large animals such as pigs [76], sheep [77], and dogs [78]. The larger size of these experimental animals makes access to and macro scale visualization of the femoral head possible. Therefore, surgery is usually performed, and the local application of alcohol or focal cryogen insults is used to induce osteonecrosis [76, 77]. However, a few large animal models that utilize steroids do exist. Drescher et al. [79] treated pigs with corticosteroids and observed contraction of femoral head lateral epiphyseal arteries in treated animals, but noted no evidence of ONFH in these pigs. In another report by Poignard et al. [80], 18 female pigs were used to creat ONFH by cryo-injury, the authors noted localized and sustainable subchondral necrosis of the femoral head, reproducing all stages of the human disease. Moreover, the good correlation between histological and MRI results indicates that the pig is a relevant model for human ONFH. Run et al. [78] established the ONFH model with 18 healthy adult dogs. In their study, group A was treated with MPS (10 mg/kg) combined with LPS (10 μg/kg), in group B, ONFH was induced by liquid nitrogen cryo-insult, and group C was a blank control group. They found that both the hormonal method and the liquid nitrogen method induced non-traumatic ONFH. They concluded, however, that the more reliable osteonecrosis level seen in their liquid nitrogen treated group made cryo-injury more suitable for the research of standardized treatment of existing ONFH. In the treatment of ONFH, Lebouvier et al. [81] found treatment of a natural pig ONFH by autologous BMSCs indicated a beginning of bone healing as early as two weeks with a complete healing after nine weeks. None of the above models have shown the reproducibility demonstrated by small mammal, chicken, and emu models of SONFH.
Selection of SONFH modeling methods
While steroid only models of SOFHN do exist, the research community has paid increasing attention the limitations of these studies. Clinically, chronic SONFH does occur without a pre-existing diseases state that necessitates steroid use. SLE, RA, chronic obstructive pulmonary disease, and organ transplantation along with acute bouts of SARS or asthma require steroid treatment. In order to better simulate the clinical setting of inflammation, the use of LPS or allogeneic serum in conjunction with steroid therapy has become more accepted as the most appropriate model of SONFH.
Glucocorticoid steroids alone modeling
The rate at which SONFH occurs in animal models has been shown to depend on the type of steroid use, dosage, and frequency of administration. All of these factors are important to consider when judiciously using steroids in the clinical setting. Zhao et al. [82] and Kang et al. [29] induced SONFH in male Japanese white rabbits with a single intramuscular injection of MPLS (20 mg / kg). The incidence of ONFH was 75% and 70% after two weeks respectively. Wang et al. [83] reported that 16 rats were given intramuscular prednisolone acetate (12.5 mg/kg) twice a week for four weeks. The incidence of SONFH was 71.43%. Motomura et al. [84] compared four different single intramuscular doses of MPS single dose injection to induce SONFH rabbit model. After four weeks, the incidence of ONFH in the 1, 5, 20, and 40 mg/kg groups was 0, 42, 70, and 96%, respectively.
Glucocorticoid steroids + endotoxin modeling
LPS, also known as endotoxin, can cause fever, microcirculation disturbances, and even endotoxic shock and disseminated intravascular coagulation. When used in combination with steroids to simulate the inflammatory host state, it reliably initiates intravascular coagulation and eventual SONFH. Yu et al. [46] used SD rats in a hormone + LPS model. LPS (4 mg/kg) was intravenously injected two times with an interval of 24 hours, after 24 hours, MPS (60 mg/kg) was intramuscularly injected three times every 24 hours, and three weeks later, the histological examination revealed that the incidence of ONFH was 73.3% with an increased empty lacunae and morphological changes of osteocytes, haematopoietic cells, and adipocytes in bone marrow. Chen et al. [61] performed a similar study in Wistar rats. LPS (2 mg/kg) was intravenously injected two times with an interval of 24 hours, 24 hours later, MPS (20 mg/kg) was intramuscularly injected three times every 24 hours. After four weeks, the incidence of ONFH was found to be 66.7% with the increase of empty lacuna, pyknotic nuclei of osteocytes, and necrosis of bone marrow cells. Dong et al. [62] used SD rats in an even more reliable model of SONFH. LPS (20 μg/kg) was intravenously injected two times every 24 hours, and after 24 hours, MPS (40 mg/kg) was intramuscularly injected three over three days. Four weeks later, the incidence of ONFH was 83.3% with an associated decrease in bone mass, trabecular thickness, bone mineral density, and serum osteocalcin concentration.
Jia et al. [27] injected 4-month-old, healthy white rats with 100 μg/kg intravenous Escherichia coli endotoxin two times over 24 hours. These injections were followed by three times daily MPS (20 mg/kg) intramuscular injections. Four weeks later, histopathology of the femoral head showed typical ONFH with thin, broken, and disordered trabecula, hypertrophic fat cells, irregular arrangement of osteoblasts, and an increase in empty lacunae. At six weeks, histopathology showed osteocyte necrosis associated with karyopyknosis, karyolysis, and karyorrhexis. Still more bone lacunae vacuoles occurred, intramedullary vessels were compressed, vascular lumens became narrow. Fat emboli and thrombus formation were also observed.
Zheng et al. [6] used ten male emus at 24 months of age in their toxin + hormone model. LPS (8 μg/kg) was intravenously injected twice over four days. Subsequently, MPS (10 mg/kg) was intramuscularly administered three times every two days. In emus treated with this regimen, MRI showed a strong edema signal in the proximal femoral head starting at week two. This edema signal decreased gradually until the 12th week, at which point gait abnormalities were observed. Micro-CT scan showed a significant reduction of BMD, bone tissue, trabecular number, and thickness of the subchondral and femoral head central regions. By 24 weeks, the rate of femoral head collapse was 70%.
Glucocorticoid steroids + allogeneic serum modeling
Allogeneic serum can induce type III hypersensitivity, a process in which medium-sized antigen-antibody complexes deposit in the basement membrane of small blood vessels resulting in capillary congestion, oedema, necrosis, and local neutrophil infiltration. This inflammatory process is not dissimilar from that seen in many of the antibody mediated auto-immune diseases treated with steroids. The vasculitis induced by this process is complicated by the introduction of steroids—which inhibit not only immune cells (their intended therapeutic), but also the synthesis of collagen and elastic fibers, which can lead to avascular necrosis of the femoral head. Wang et al. [37] injected a sensitizing dose of horse serum (10 ml/mg) intravenously into rabbits and then injected 6 ml/kg of horse serum one daily for two days two weeks later. MPS (20 mg/kg) was then injected intraperitoneally twice weekly for two weeks. Two weeks later, MRI examination showed that rabbits in the treatment group had a larger joint cavity in the femoral head, a high level of T2WI signal in the metaphysis and bone marrow oedema. Hyperlipidemia and loss of femoral head cartilage coverage were also observed. Bony trabeculae were decreased and thinned, while bone marrow haematopoietic cells and osteocytes were decreased in number. This was all seen in the setting of shrunken capillary bed with numerous partially obstructed vessels.
In a similar study, Tian et al. [33] sensitized rabbits with horse serum (10 ml/kg) and then three weeks later injected a single dose of 7.5 mg/ml horse serum. After an additional two weeks, MPS (45 mg/kg) was injected intramuscularly once a day for three days. Observation at two weeks showed some early osteonecrosis, which was fulminant in 54% of the treated mice by week eight. Trabecular bone showed necrotic changes, with osteoclast and fibroblast invasion of the trabeculae tissue.
Identification of SONFH in animal models
The most commonly used method for identification of SONFH in experimental models is histopathology. The histopathology of osteonecrosis is characterized by the presence of sparse or fragmented trabeculae, disorganization of tissue, reduction of haematopoietic cells in the bone marrow, oedema of adipocytes, and microvascular occlusion with thrombi or fat emboli [27]. This approach is reliable for small animals not amenable to conventional imaging studies, but has limited clinical application to practitioners who must often made this diagnosis based on plain film or MRI imaging.
Clinically, the course of SONFH is gradual. Early diagnosis and treatment limit the morbidity and economic burden associated with the disease. Chen et al. [85] showed that MRI is a highly sensitive method for the diagnosis of early ONFH, when articular cartilage and the bony interface between femur and acetabulum do not yet appear abnormal on plain radiographs. Later in the course of disease, in large animals like the emu, plain film radiographs show characteristic decreased bone density, cystic degeneration of the femoral head. Micro-CT can be applied to animal models of all sizes and defines bony architecture more clearly than plain radiographs. Recent studies have shown that angiography can also be used to identify the animal models of SONFH. Zhang et al. found fewer vessel-like structures in femoral heads by angiograph with associated, many vacuoles occupying a large area of the subchondral region [39].
Summary
In summary, scholars from across the globe have developed a variety of animal models of SONFH and focused their studies on pathogenesis, prevention, and treatment of SONFH. Despite all of this work, the ideal animal model has not yet been identified. While rodents have predominated early research, their four-legged gait and small body weight make application of their disease process imperfect. Larger animals, such as pigs and dogs ameliorate the weight discrepancy, but ambulate with biomechanics that differ significantly from humans. In fact, induction of true femoral collapse has proven difficult, despite its frequency in the human population suffering from SONFH. Bipedal animals such as chicken and emu walk in a similar manner to human beings and the weight of the emus more closely mirrors human body weight. These similarities allow for true femoral head collapse in emu models of SONFH. Significant differences in bloody supply to the femoral head between birds and mammals have been identified and could possibly change the stepwise pathology of the disease. The variety of induction methods (steroid only, steroid + toxin, and steroid + allogeneic serum) make comparing study results challenging, but likely reflect the varied inflammatory milieu present in humans who are treated with steroids for a variety of conditions.
The ideal combination of animal, induction regimen, and identification tool for the study of SONFH has not yet been established. Creating a replicating such an experimental model will allow for more effective study and treatment of SONFH, leading to improved clinical outcomes at reduced cost to the individual and the health care system.
References
Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124
Chan MH, Chan PK, Griffith JF, Chan IH, Lit LC, Wong CK, Antonio GE, Liu EY, Hui DS, Suen MW, Ahuja AT, Sung JJ, Lam CW (2006) Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy. Pathology 38:229–235
Law RK, Lee EW, Poon PY, Lau TC, Kwok KM, Chan AC (2008) The functional capacity of healthcare workers with history of severe acute respiratory distress syndrome (SARS) complicated with avascular necrosis—case report. Work 30:17–26
Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR (2003) Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 52:337–355
Mont MA, Jones LC, Hungerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117–1132
Zheng LZ, Liu Z, Lei M, Peng J, He YX, Xie XH, Man CW, Huang L, Wang XL, Fong DT, Xiao DM, Wang DP, Chen Y, Feng JQ, Liu Y, Zhang G, Qin L (2013) Steroid-associated hip joint collapse in bipedal emus. PLoS One 8:e76797
Zhou L, Weng XS (2013) Selection and application of animal model of steroid-induced femoral head necrosis (In Chinese). Orthopedic Journal of China: 2155–2158
Liu G, Luo G, Bo Z, Liang X, Huang J, Li D (2016) Impaired osteogenic differentiation associated with connexin 43/micro RNA-206 in steroid-induced avascular necrosis of the femoral head. Exp Mol Pathol 101:89–99
Fan L, Li J, Yu Z, Dang X, Wang K (2014) Hypoxia-inducible factor prolyl hydroxylase inhibitor prevents steroid-associated osteonecrosis of the femoral head in rabbits by promoting angiogenesis and inhibiting apoptosis. PLoS One 9:e107774
Li J, Li Y, Wang Y, Liu M, Zhao G (2014) Preventive effects of si RNA targeting PPARgamma gene on steroid-induced osteonecrosis in rabbits. Connect Tissue Res 55:322–330
Wu Z, Ji C, Li H, Qiu G, Gao C, Weng X (2013) Elevated level of membrane microparticles in the disease of steroid-induced vascular osteonecrosis. J Craniofac Surg 24:1252–1256
Kang PD, Shen B, Yang J, Dang HS, Pei FX (2007) Platelet and endothelial cell-derived microparticles in steroid-induced osteonecrosis of the femoral head of rabbit model (in Chinese). Natl Med J China: 2045-2049
Guan XY, Han D (2010) Role of hypercoagulability in steroid-induced femoral head necrosis in rabbits. J Orthop Sci 15:365–370
Ball SG, Shuttleworth CA, Kielty CM (2007) Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 11:1012–1030
Wang G, Zhang CQ, Sun Y, Feng Y, Chen SB, Cheng XG, Zeng BF (2010) Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis. J Int Med Res 38:1060–1069
Li Y, Chen J, Zhang Z, Wang K, Tong Z, Yan H (2004) The experimental study on treatment of glucocorticoid-induced ischemic necrosis of femoral head by gu fu sheng capsule. J Tradit Chin Med 24:303–307
He W, Xu C, Fan Y, Fang B, Li X, Wang H, Liu S, Yuan H (2004) Effects of the Chinese drugs for activating blood circulation on plasma TXB2 and 6-keto-PGF1alpha contents in rabbits with glucocorticoid-induced femoral head necrosis. J Tradit Chin Med 24:233–237
Yuan P, He X, Zhou H, Wang G, Wang D, Li H (2005) Experimental study on gufusheng in treatment of steroid-induced ischemic necrosis of femoral head in rabbits. J Tradit Chin Med 25:300–303
Qi ZX, Chen L (2009) Effect of Chinese drugs for promoting blood circulation and eliminating blood stasis on vascular endothelial growth factor expression in rabbits with glucocorticoid-induced ischemic necrosis of femoral head. J Tradit Chin Med 29:137–140
Wu J, Yao L, Wang B, Liu Z, Ma K (2016) Tao-Hong-Si-Wu Decoction ameliorates steroid-induced avascular necrosis of the femoral head by regulating the HIF-1alpha pathway and cell apoptosis. Biosci Trends 10:410–417
Pengde K, Fuxing P, Bin S, Jing Y, Jingqiu C (2008) Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 75:696–701
Nishida K, Yamamoto T, Motomura G, Jingushi S, Iwamoto Y (2008) Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop Relat Res 466:1054–1058
Kang P, Gao H, Pei F, Shen B, Yang J, Zhou Z (2010) Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Int J Exp Pathol 91:235–243
Beckmann R, Shaheen H, Kweider N, Ghassemi A, Fragoulis A, Hermanns-Sachweh B, Pufe T, Kadyrov M, Drescher W (2014) Enoxaparin prevents steroid-related avascular necrosis of the femoral head. Sci World J 2014:347813
Kuribayashi M, Fujioka M, Takahashi KA, Arai Y, Ishida M, Goto T, Kubo T (2010) Vitamin E prevents steroid-induced osteonecrosis in rabbits. Acta Orthop 81:154–160
Mikami T, Ichiseki T, Kaneuji A, Ueda Y, Sugimori T, Fukui K, Matsumoto T (2010) Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model. J Orthop Sci 15:674–677
Jia YB, Jiang DM, Ren YZ, Liang ZH, Zhao ZQ, Wang YX (2017) Inhibitory effects of vitamin E on osteocyte apoptosis and DNA oxidative damage in bone marrow hemopoietic cells at early stage of steroid-induced femoral head necrosis. Mol Med Rep 15:1585–1592
Asada T, Kushida T, Umeda M, Oe K, Matsuya H, Wada T, Sasai K, Ikehara S, Iida H (2008) Prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells. Rheumatology (Oxford) 47:591–596
Kang P, Xie X, Tan Z, Yang J, Shen B, Zhou Z, Pei F (2015) Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs. J Mater Sci Mater Med 26:80
Sun Y, Feng Y, Zhang C (2009) The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine 76:685–690
Sun Y, Feng Y, Zhang C, Cheng X, Chen S, Ai Z, Zeng B (2011) Beneficial effect of autologous transplantation of endothelial progenitor cells on steroid-induced femoral head osteonecrosis in rabbits. Cell Transplant 20:233–243
Xie XH, Wang XL, He YX, Liu Z, Sheng H, Zhang G, Qin L (2012) Promotion of bone repair by implantation of cryopreserved bone marrow-derived mononuclear cells in a rabbit model of steroid-associated osteonecrosis. Arthritis Rheum 64:1562–1571
Tian L, Dang XQ, Wang CS, Yang P, Zhang C, Wang KZ (2013) Effects of sodium ferulate on preventing steroid-induced femoral head osteonecrosis in rabbits. J Zhejiang Univ Sci B 14:426–437
Zhai JL, Weng XS, Wu ZH, Guo SG (2016) Effect of resveratrol on preventing steroid-induced osteonecrosis in a rabbit model. Chin Med J 129:824–830
Drescher W, Beckmann R, Kasch R, Pufe M, Knobe M, Kweider N, Hassenpflug J, Tingart M, Pufe T, Kadyrov M (2011) Nitrate patch prevents steroid-related bone necrosis. J Orthop Res 29:1517–1520
Kuroda Y, Akiyama H, Kawanabe K, Tabata Y, Nakamura T (2010) Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres. J Bone Miner Metab 28:608–616
Wang L, Luo DK, Pan ZY (2013) Expression of 11beta-HSD in steroid-induced avascular necrosis of the femoral head. Mol Med Rep 7:1482–1486
Dong YL, Zhou L, Li YL, Xiao K, Weng XS (2015) Establishment and assessment of rat models of glucocorticoid-induced osteonecrosi (In Chinese). Acta Academiae Medicinae Sinicae:152–156
Zhang Y, Yin J, Ding H, Zhang C, Gao YS (2016) Vitamin K2 ameliorates damage of blood vessels by glucocorticoid: a potential mechanism for its protective effects in glucocorticoid-induced osteonecrosis of the femoral head in a rat model. Int J Biol Sci 12:776–785
Han N, Yan Z, Guo CA, Shen F, Liu J, Shi Y, Zhang Z (2010) Effects of p-glycoprotein on steroid-induced osteonecrosis of the femoral head. Calcif Tissue Int 87:246–253
Han N, Yan ZQ, Guo CA, Shen F, Liu J, Shi YX, Zhang ZY (2010) Effect of rifampicin on the risk of steroid-induced osteonecrosis of the femoral head. Orthop Surg 2:124–133
Han N, Li Z, Cai Z, Yan Z, Hua Y, Xu C (2016) P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head. J Cell Mol Med 20:2173–2182
Nozaki Y, Kumagai K, Miyata N, Niwa M (2012) Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats. Acta Orthop 83:87–92
Jiang Y, Zhang Y, Zhang H, Zhu B, Li P, Lu C, Xu Y, Chen W, Lin N (2014) Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARgamma expression and activating Wnt signaling pathway. Exp Biol Med (Maywood) 239:347–355
Zhang C, Zou YL, Ma J, Dang XQ, Wang KZ (2015) Apoptosis associated with Wnt/beta-catenin pathway leads to steroid-induced avascular necrosis of femoral head. BMC Musculoskelet Disord 16:132
Yu Z, Fan L, Li J, Ge Z, Dang X, Wang K (2016) Lithium prevents rat steroid-related osteonecrosis of the femoral head by beta-catenin activation. Endocrine 52:380–390
Yu Z, Fan L, Li J, Ge Z, Dang X, Wang K (2015) Lithium chloride attenuates the abnormal osteogenic/adipogenic differentiation of bone marrow-derived mesenchymal stem cells obtained from rats with steroid-related osteonecrosis by activating the beta-catenin pathway. Int J Mol Med 36:1264–1272
Okazaki S, Nishitani Y, Nagoya S, Kaya M, Yamashita T, Matsumoto H (2009) Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway. Rheumatology (Oxford) 48:227–232
Tian L, Wen Q, Dang X, You W, Fan L, Wang K (2014) Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis. BMC Musculoskelet Disord 15:18
Komurcu E, Oktay M, Kaymaz B, Hatay Golge U, Goksel F, Nusran G (2014) Preventive effects of coenzyme Q10 (CoQ10) on steroid-induced osteonecrosis in rats. Acta Orthop Traumatol Turc 48:217–222
Miyata N, Kumagai K, Osaki M, Murata M, Tomita M, Hozumi A, Nozaki Y, Niwa M (2010) Pentosan reduces osteonecrosis of femoral head in SHRSP. Clin Exp Hypertens 32:511–516
Okazaki S, Nagoya S, Matsumoto H, Mizuo K, Shimizu J, Watanabe S, Inoue H, Yamashita T (2016) TLR4 stimulation and corticosteroid interactively induce osteonecrosis of the femoral head in rat. J Orthop Res 34:342–345
Tong P, Wu C, Jin H, Mao Q, Yu N, Holz JD, Shan L, Liu H, Xiao L (2011) Gene expression profile of steroid-induced necrosis of femoral head of rats. Calcif Tissue Int 89:271–284
Kerachian MA, Cournoyer D, Harvey EJ, Chow TY, Begin LR, Nahal A, Seguin C (2010) New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model. Arthritis Res Ther 12:R124
Carli AV, Harvey EJ, Azeddine B, Gao C, Li Y, Li A, Sayegh M, Wang H, Nahal A, Michel RP, Henderson JE, Seguin C (2017) Substrain-specific differences in bone parameters, alpha-2-macroglobulin circulating levels, and osteonecrosis incidence in a rat model. J Orthop Res 35:1183–1194
Zhao JJ, Wu ZF, Wang L, Feng DH, Cheng L (2016) MicroRNA-145 mediates steroid-induced necrosis of the femoral head by targeting the OPG/RANK/RANKL signaling pathway. PLoS One 11:e0159805
Tao SC, Yuan T, Rui BY, Zhu ZZ, Guo SC, Zhang CQ (2017) Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway. Theranostics 7:733–750
Chen Y, Huang K, Lang F, Huang Y, Huang H, Huang H, Zhou C, Zhang W (2003) Experimental study on cheng zai wan for treatment of necrosis of the femoral head. J Tradit Chin Med 23:292–298
Wu CL, Mao Q, Jin HT, Xiao LW, Tong PJ (2012) Study on the effect of Youguiyin () on regulating gene expression profile of the rats with femoral head necrosis induced by steroid. Chin J Integr Med 18:269–275
Shi B, Li G, Wang P, Yin W, Sun G, Wu Q, Yu G (2010) Effect of antler extract on corticosteroid-induced avascular necrosis of the femoral head in rats. J Ethnopharmacol 127:124–129
Chen S, Li J, Peng H, Zhou J, Fang H (2014) Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats. Int J Mol Med 33:840–848
Dong Y, Li Y, Huang C, Gao K, Weng X (2015) Systemic application of teriparatide for steroid induced osteonecrosis in a rat model. BMC Musculoskelet Disord 16:163
Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis—a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86:1209–1213
Ryoo S, Lee S, Jo S, Lee S, Kwak A, Kim E, Lee J, Hong J, Jhun H, Lee Y, Sobti AS, Kim S, Oh KJ (2014) Effect of lipopolysaccharide (LPS) on mouse model of steroid-induced avascular necrosis in the femoral head (ANFH). J Microbiol Biotechnol 24:394–400
Wang B, Yu P, Li T, Bian Y, Weng X (2015) MicroRNA expression in bone marrow mesenchymal stem cells from mice with steroid-induced osteonecrosis of the femoral head. Mol Med Rep 12:7447–7454
Yang L, Boyd K, Kaste SC, Kamdem Kamdem L, Rahija RJ, Relling MV (2009) A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res 27:169–175
Cui Q, Wang GJ, Su CC, Balian G (1997) The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res:8–19
Chen WH, Kong XY, Wan R, Xiao CS, Li L, Wang ZY, Lin N, Wang HM (2012) Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. Chin J Integr Med 18:378–384
Erken HY, Ofluoglu O, Aktas M, Topal C, Yildiz M (2012) Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head: experimental study in chicken. Int Orthop 36:1523–1528
Xu J, Wang X, Toney CB, Seamon J, Cui Q (2010) Blood supply to the chicken femoral head. Comp Med 60:295–299
Conzemius MG, Brown TD, Zhang Y, Robinson RA (2002) A new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure. J Orthop Res 20:303–309
Goetz JE, Pedersen DR, Robinson DA, Conzemius MG, Baer TE, Brown TD (2008) The apparent critical isotherm for cryoinsult-induced osteonecrotic lesions in emu femoral heads. J Biomech 41:2197–2205
Troy KL, Brown TD, Conzemius MG (2009) Contact stress distributions on the femoral head of the emu (Dromaius novaehollandiae). J Biomech 42:2495–2500
Reed KL, Brown TD, Conzemius MG (2003) Focal cryogen insults for inducing segmental osteonecrosis: computational and experimental assessments of thermal fields. J Biomech 36:1317–1326
Fan M, Peng J, Wang A, Zhang L, Liu B, Ren Z, Xu W, Sun J, Xu L, Xiao D, Qin L, Lu S, Wang Y, Guo QY (2011) Emu model of full-range femoral head osteonecrosis induced focally by an alternating freezing and heating insult. J Int Med Res 39:187–198
Hofstaetter JG, Roschger P, Klaushofer K, Kim HK (2010) Increased matrix mineralization in the immature femoral head following ischemic osteonecrosis. Bone 46:379–385
Velez R, Soldado F, Hernandez A, Barber I, Aguirre M (2011) A new preclinical femoral head osteonecrosis model in sheep. Arch Orthop Trauma Surg 131:5–9
Ruan KM (2014) The comparative application of hormonal method and liquid nitrogen method in modeling of femoral head necrosis in dogs (in Chinese). In. Fujian Medical University
Drescher W, Bunger MH, Weigert K, Bunger C, Hansen ES (2004) Methylprednisolone enhances contraction of porcine femoral head epiphyseal arteries. Clin Orthop Relat Res:112–117
Poignard A, Lebouvier A, Cavet M, Rahmouni A, Flouzat Lachaniette CH, Bierling P, Rouard H, Hernigou P, Chevallier N (2014) New preclinical porcine model of femoral head osteonecrosis to test mesenchymal stromal cell efficiency in regenerative medicine. Int Orthop 38:1837–1844
Lebouvier A, Poignard A, Cavet M, Amiaud J, Leotot J, Hernigou P, Rahmouni A, Bierling P, Layrolle P, Rouard H, Chevallier N (2015) Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection. Stem Cell Res Ther 6:68
Zhao G, Yamamoto T, Motomura G, Yamaguchi R, Ikemura S, Iwasaki K, Iwamoto Y (2013) Cholesterol- and lanolin-rich diets may protect against steroid-induced osteonecrosis in rabbits. Acta Orthop 84:593–597
Wang JZ, Gao HY, Wang KZ, Zhou RX, Li XD, Guo J, Lv HC (2011) Effect of epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats (in Chinese). J Southern Med Univ:1714-1717
Motomura G, Yamamoto T, Irisa T, Miyanishi K, Nishida K, Iwamoto Y (2008) Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol 35:2395–2399
Chen XC, Weng J, Chen XQ, Du JZ, Zhu MP, Pan YQ, Liu M (2008) Relationships among magnetic resonance imaging, histological findings, and IGF-I in steroid-induced osteonecrosis of the femoral head in rabbits. J Zhejiang Univ Sci B 9:739–746
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Cui or an immediate family member serves as a paid consultant to Exactech; has received research or institutional support from National Institute of Health, Department of Defense and Exactech; and serves as a board member, owner, officer, or committee member of the Virginia Orthopedic Society, Journal of Arthroplasty, Journal of Orthopedic Research, and World Journal of Orthopedics; received royalties from Elsevier. None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Xu, Dr. Gong, Dr. Lu, and Dr. Deasey.
Rights and permissions
About this article
Cite this article
Xu, J., Gong, H., Lu, S. et al. Animal models of steroid-induced osteonecrosis of the femoral head—a comprehensive research review up to 2018. International Orthopaedics (SICOT) 42, 1729–1737 (2018). https://doi.org/10.1007/s00264-018-3956-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-018-3956-1